239 related articles for article (PubMed ID: 22826319)
1. A c-Myc and surface CD19 signaling amplification loop promotes B cell lymphoma development and progression in mice.
Poe JC; Minard-Colin V; Kountikov EI; Haas KM; Tedder TF
J Immunol; 2012 Sep; 189(5):2318-25. PubMed ID: 22826319
[TBL] [Abstract][Full Text] [Related]
2. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
[TBL] [Abstract][Full Text] [Related]
3. CD19 function in early and late B cell development: I. Maintenance of follicular and marginal zone B cells requires CD19-dependent survival signals.
Otero DC; Anzelon AN; Rickert RC
J Immunol; 2003 Jan; 170(1):73-83. PubMed ID: 12496385
[TBL] [Abstract][Full Text] [Related]
4. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
5. CD19 function in early and late B cell development. II. CD19 facilitates the pro-B/pre-B transition.
Otero DC; Rickert RC
J Immunol; 2003 Dec; 171(11):5921-30. PubMed ID: 14634103
[TBL] [Abstract][Full Text] [Related]
6. Severely impaired B lymphocyte proliferation, survival, and induction of the c-Myc:Cullin 1 ubiquitin ligase pathway resulting from CD22 deficiency on the C57BL/6 genetic background.
Poe JC; Haas KM; Uchida J; Lee Y; Fujimoto M; Tedder TF
J Immunol; 2004 Feb; 172(4):2100-10. PubMed ID: 14764675
[TBL] [Abstract][Full Text] [Related]
7. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice.
Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A
Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759
[TBL] [Abstract][Full Text] [Related]
8. CD19 signaling pathways play a major role for murine AIDS induction and progression.
Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
[TBL] [Abstract][Full Text] [Related]
9. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
[TBL] [Abstract][Full Text] [Related]
10. A CD19-dependent signaling pathway regulates autoimmunity in Lyn-deficient mice.
Hasegawa M; Fujimoto M; Poe JC; Steeber DA; Lowell CA; Tedder TF
J Immunol; 2001 Sep; 167(5):2469-78. PubMed ID: 11509585
[TBL] [Abstract][Full Text] [Related]
11. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
[TBL] [Abstract][Full Text] [Related]
12. Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.
Nilsson LM; Keller UB; Yang C; Nilsson JA; Cleveland JL; Roussel MF
Oncogene; 2007 May; 26(20):2833-9. PubMed ID: 17099725
[TBL] [Abstract][Full Text] [Related]
13. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19.
Sato S; Miller AS; Howard MC; Tedder TF
J Immunol; 1997 Oct; 159(7):3278-87. PubMed ID: 9317126
[TBL] [Abstract][Full Text] [Related]
14. BAFF-driven autoimmunity requires CD19 expression.
Fairfax KA; Tsantikos E; Figgett WA; Vincent FB; Quah PS; LePage M; Hibbs ML; Mackay F
J Autoimmun; 2015 Aug; 62():1-10. PubMed ID: 26103922
[TBL] [Abstract][Full Text] [Related]
15. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity.
Watanabe R; Ishiura N; Nakashima H; Kuwano Y; Okochi H; Tamaki K; Sato S; Tedder TF; Fujimoto M
J Immunol; 2010 May; 184(9):4801-9. PubMed ID: 20368271
[TBL] [Abstract][Full Text] [Related]
16. Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19.
Taylor DK; Ito E; Thorn M; Sundar K; Tedder T; Spatz LA
Mol Immunol; 2006 Apr; 43(11):1776-90. PubMed ID: 16430962
[TBL] [Abstract][Full Text] [Related]
17. Differential phosphorylation of functional tyrosines in CD19 modulates B-lymphocyte activation.
Ishiura N; Nakashima H; Watanabe R; Kuwano Y; Adachi T; Takahashi Y; Tsubata T; Okochi H; Tamaki K; Tedder TF; Fujimoto M
Eur J Immunol; 2010 Apr; 40(4):1192-204. PubMed ID: 20101619
[TBL] [Abstract][Full Text] [Related]
18. MIF loss impairs Myc-induced lymphomagenesis.
Talos F; Mena P; Fingerle-Rowson G; Moll U; Petrenko O
Cell Death Differ; 2005 Oct; 12(10):1319-28. PubMed ID: 15947793
[TBL] [Abstract][Full Text] [Related]
19. PTEN and PI-3 kinase inhibitors control LPS signaling and the lymphoproliferative response in the CD19+ B cell compartment.
Singh AR; Peirce SK; Joshi S; Durden DL
Exp Cell Res; 2014 Sep; 327(1):78-90. PubMed ID: 24881819
[TBL] [Abstract][Full Text] [Related]
20. The Transcription Factor ASCIZ and Its Target DYNLL1 Are Essential for the Development and Expansion of MYC-Driven B Cell Lymphoma.
Wong DM; Li L; Jurado S; King A; Bamford R; Wall M; Walia MK; Kelly GL; Walkley CR; Tarlinton DM; Strasser A; Heierhorst J
Cell Rep; 2016 Feb; 14(6):1488-1499. PubMed ID: 26832406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
